research

Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder

Abstract

This study was funded by Pfizer Inc. Editorial support to prepare this manuscript for submission was provided by Lorna Forse, PhD, of Engage Scientific Solutions and funded by Pfizer In

    Similar works